@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/naltv#marc001> rdfs:label "Field 001 in MARC Authority Format"@en .
nalt:313030_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "Cerebrosides which contain as their polar head group a glucose moiety bound in glycosidic linkage to the hydroxyl group of ceramides. Their accumulation in tissue, due to a defect in beta-glucosidase, is the cause of Gaucher's disease."@en, "Cerebrósidos que contienen como grupo cabeza polar fracciones de glucosa unidas en el enlace glucosídico al grupo hidroxilo de las ceramidas. Su acumulación en los tejidos, como resultado de un defecto en la betaglucosidasa, es la causa de la enfermedad de Gaucher."@es ;
  dc:source "Medical Subject Headings 2018" .

<https://lod.nal.usda.gov/nalt>
  a skos:ConceptScheme ;
  rdfs:label "NALT Full"@en .

<https://lod.nal.usda.gov/naltv#Chemical>
  a owl:Class ;
  rdfs:label "Chemical"@en .

nalt:313030
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  dc:created "2018-02-06"^^xsd:date ;
  dc:modified "2018-11-14"^^xsd:date ;
  skos:altLabel "glucosyl ceramides"@en ;
  skos:broader nalt:24055 ;
  skos:definition nalt:313030_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:prefLabel "glucosilceramidas"@es, "glucosylceramides"@en ;
  ns0:marc001 "87500" .

nalt:24055
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:313030 ;
  skos:prefLabel "cerebrósidos"@es, "cerebrosides"@en .